Portugal Mais

«LOURES, Portugal, April 15 /PRNewswire/ -- Hovione is pleased to announcethat its licensee Daiichi Sankyo (Tokyo, Japan) has informed that it intendsto use Hovione's TwinCaps(R) dry powder inhaler device in the launch of thecompound CS-8958, an inhaled long-acting neuraminidase inhibitor activeagainst the influenza viru (...).

The announcement follows the recent publication(1) of data indicatingthat the compound is as effective as Relenza(R) and Tamiflu(R) againstvarious influenza strains. Significantly this efficacy is achieved with asingle dose, as opposed to a treatment over five days for the establisheddrugs(...).»

A multinacional portuguesa Hovione na vanguarda do combate ao virus da gripe.